These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2473272)

  • 21. Recurrent meningococcal meningitis associated with deficiencies of C8 and anti-meningococcal antibody.
    Cooke RP; Zafar M; Haeney MR
    J Clin Lab Immunol; 1987 May; 23(1):53-6. PubMed ID: 3112405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningococcal carriage and immunity in western Burkina Faso, 2003.
    Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
    Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the antigenic properties of strains of Neisseria meningitidis isolated from the cerebrospinal fluid of patients with meningitis].
    Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):91-9. PubMed ID: 3157468
    [No Abstract]   [Full Text] [Related]  

  • 24. Meningococcal meningitis in children: clinical comparison of disease produced by the minor and major serologic groups of Neisseria meningitidis.
    Ryan NJ; Hogan GR; Bonner MC
    South Med J; 1984 Oct; 77(10):1234-9. PubMed ID: 6435254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serogrouping of non-interpretable Neisseria meningitidis carriage strains, using rapid diagnostic tests.
    Hamidou AA; Djibo S; Mamane AE; Moussa A; Chanteau S
    Trans R Soc Trop Med Hyg; 2008 Jan; 102(1):99-100. PubMed ID: 17976669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulphadiazine-resistant Neisseria meningitidis Group A: immunoelectro-osmophoresis technique for the rapid diagnosis of meningococcal meningitis.
    Gebre-Yohannes A; Gebre-Sellassie L
    Ethiop Med J; 1982 Apr; 20(2):107-8. PubMed ID: 6806094
    [No Abstract]   [Full Text] [Related]  

  • 27. The chick embryo neutralization test in the assay of meningococcal antibody. 3. Dynamics and specificity of the sero-protection test.
    Ueda K; Diena BB; Wallace R; Sato H; Greenberg L
    Rev Can Biol; 1971 Mar; 30(1):1-9. PubMed ID: 4998556
    [No Abstract]   [Full Text] [Related]  

  • 28. [Soviet reference sera and their use in the control of the quality of biochemical studies].
    Garanina EN; Golovchenko OM
    Lab Delo; 1988; (6):71-3. PubMed ID: 2459491
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the socio-economic effect of using immune anti- meningococcal plasma in pediatric practice].
    Smirnova AI; Kochetygina AA; Nikolaeva LK; Zinchenko AP; Sorokina MN; Romanchenko TG
    Pediatriia; 1990; (3):36-9. PubMed ID: 2143575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The composition of immune sera against Neisseria meningitidis studied by high-performance liquid chromatography].
    Filatova TN; Churakova NI; Titova EV; Filippov IuV; Vartanian IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):52-5. PubMed ID: 3146189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: Miningococcal meningitis.
    Vella EE; Goode D
    Trans R Soc Trop Med Hyg; 1975; 69(4):439. PubMed ID: 766325
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged fever in bacterial meningitis.
    Fallon RJ
    Br Med J; 1971 Dec; 4(5787):623. PubMed ID: 5002117
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of trypsinized meningococci to obtain highly specific sera].
    Lifanova II; Litinskiĭ IuI; Golovinova MA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):56-60. PubMed ID: 96636
    [No Abstract]   [Full Text] [Related]  

  • 34. Test antiserum for group B meningococci.
    Robbins JB
    Br Med J; 1977 May; 1(6070):1220. PubMed ID: 405072
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality control experiences with febrile agglutinins in serum.
    Carter PK; Schoen I
    Am J Clin Pathol; 1970 Mar; 53(3):364-9. PubMed ID: 5416773
    [No Abstract]   [Full Text] [Related]  

  • 36. [Governmental testing of fluorescence labeled test sera].
    Patzwaldt HG; Markuse I
    Z Gesamte Hyg; 1976 Jan; 22(1):45-7. PubMed ID: 960809
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of agglutinizing and complement binding properties of antimeningococcic sera.
    MONOSSOHN RI
    Mikrobiologiia; 1945; 14(9):87. PubMed ID: 21027479
    [No Abstract]   [Full Text] [Related]  

  • 38. Standardisation and control of blood-typing sera. International and national organizations.
    Goldsmith KL
    Rev Fr Transfus; 1969 Mar; 12(1):13-24. PubMed ID: 5775250
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assessment of diagnostic sera of the intestinal group by antibody nitrogen].
    Bogoiavlenskaia LB; Ershova EB
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):75-8. PubMed ID: 5875679
    [No Abstract]   [Full Text] [Related]  

  • 40. [Protection of inventions in the field of vaccines and sera].
    Korovkin VI; Shepelev NP; Dzagurov SG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):118-23. PubMed ID: 899417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.